https://www.alphaview.kr/news/41580-new-ibm-study-finds-cios-and-ctos-face-growing-ai-control-gap-as-enterprise-depl AlphaView ko 2026-06-08T05:01:00.000Z New IBM Study Finds CIOs and CTOs Face Growing AI Control Gap as Enterprise Deployment Scales https://www.alphaview.kr/news/41579-volitionrx-announces-pricing-of-46-million-public-offering AlphaView ko 2026-06-07T23:30:00.000Z VolitionRx Announces Pricing of $4.6 Million Public Offering https://www.alphaview.kr/news/41578-amgen-presents-new-data-across-its-cardiometabolic-portfolio-at-american-diabete AlphaView ko 2026-06-07T21:45:00.000Z AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS https://www.alphaview.kr/news/41577-lillys-foundayo-orforglipron-the-only-oral-glp-1-taken-without-food-or-water-res AlphaView ko 2026-06-07T16:00:00.000Z Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause https://www.alphaview.kr/news/41576-looney-tunes-land-now-open-at-six-flags-magic-mountain AlphaView ko 2026-06-07T05:08:00.000Z Looney Tunes™ Land Now Open at Six Flags Magic Mountain https://www.alphaview.kr/news/41575-duke-energy-offers-tips-to-save-energy-and-money-as-temperatures-rise-in-the-car AlphaView ko 2026-06-07T00:05:00.000Z Duke Energy offers tips to save energy and money as temperatures rise in the Carolinas https://www.alphaview.kr/news/41574-lillys-triple-agonist-retatrutide-drove-substantial-improvements-in-weight-a1c-k AlphaView ko 2026-06-06T19:30:00.000Z Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications https://www.alphaview.kr/news/41573-bitmine-immersion-technologies-kondigt-prijsstelling-aan-van-verhoogde-aanbiedin AlphaView ko 2026-06-06T19:01:00.000Z Bitmine Immersion Technologies kondigt prijsstelling aan van verhoogde aanbieding van eeuwigdurende preferente aandelen uit Serie A https://www.alphaview.kr/news/41572-bitmine-immersion-technologies-gibt-die-preisgestaltung-fr-die-aufgestockte-emis AlphaView ko 2026-06-06T18:53:00.000Z Bitmine Immersion Technologies gibt die Preisgestaltung für die aufgestockte Emission von unbefristeten Vorzugsaktien der Serie A bekannt https://www.alphaview.kr/news/41571-quantinum-anuncia-el-cierre-de-su-oferta-pblica-inicial-ampliada AlphaView ko 2026-06-06T15:15:00.000Z Quantinum anuncia el cierre de su oferta pública inicial ampliada https://www.alphaview.kr/news/41570-quantinuum-gibt-abschluss-des-erweiterten-brsengangs-bekannt AlphaView ko 2026-06-06T15:06:00.000Z Quantinuum gibt Abschluss des erweiterten Börsengangs bekannt https://www.alphaview.kr/news/41569-new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-dia AlphaView ko 2026-06-06T14:00:00.000Z New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis